COVID-19

Duke is committed to prioritizing the accessibility of our COVID-19-related technologies

Recently, OLV has seen a flood of new inventions related to the ongoing pandemic. This page is designed to help you rapidly navigate the process from invention to seeing your product make a difference for patients, providers, and the community. OLV wants to help!

View our Technologies

File an Invention Disclosure

Invention Disclosure Form

Please note that you will need to log into the Duke network to access the form. You may also submit an Invention Report using a paper version of the form. If you would like to use the paper form, please contact OLV at info-olv@duke.edu

COMPLETE DISCLOSURE FORM


Talk with a Licensing Representative

Need time with an OLV staff member who can help you think about connecting to potential partners in industry like pharmaceutical, diagnostic, and medical device companies?

Get in touch

COVID-19 Licensing Guidelines

The COVID-19 pandemic has rapidly moved the work of technology transfer offices from university and other non-profit research organizations to the battle’s front line. In order to support Membership worldwide and enable a swift end to the crisis, AUTM is providing these guidelines, which are consistent with the Association’s long-standing support for humanitarian licensing. The AUTM Board of Directors endorses these COVID-19 Licensing Guidelines, and has invited Duke and many other institutions to do the same.

  1. Technology transfer accelerates innovations that impact society and promotes the broad distribution of public health solutions. We encourage intellectual property (IP) owners to adopt a COVID-19 licensing strategy that facilitates rapid pandemic response by licensees and to make the execution of associated transactions a top priority.
  2. For most technologies, where legally possible, this strategy is best accomplished by adopting time-limited, non-exclusive royalty-free licenses, in exchange for the licensees’ commitment to rapidly make and broadly distribute products and services to prevent, diagnose, treat and contain COVID-19 and protect healthcare workers during the pandemic (as defined by the World Health Organization).
  3. Licenses may subsequently convert to a more typical commercial license as appropriate. Licenses must also preserve the licensor’s freedom to publish and use the intellectual property for teaching and research.

AUTM has long supported expediting research from academic and government labs around the world to the public for the good of society, as exemplified in the 2007 Nine Points to Consider in Licensing University Technology framework. Now more than ever it is important for technology transfer offices to reinforce these principles.

 

Learn more at AUTM